Christopher Yau
Has grant
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
Recent Grants
Grant: Close
Turing AI Fellowship: clinAIcan - developing clinical applications of artificial intelligence for cancer
Open Date: 2022-03-01
Close Date: 2025-12-31
Grant: Close
Interpretable statistical machine learning approaches for the molecular investigation of cancer
Open Date: 2021-09-30
Close Date: 2025-09-29
Grant: Close
Multimorbidity and Pregnancy: Determinants, Clusters, Consequences and Trajectories (MuM-PreDiCT)
Open Date: 2021-08-31
Close Date: 2024-08-30
Grant: Close
Turing AI Fellowship: clinAIcan - developing clinical applications of artificial intelligence for cancer
Open Date: 2021-01-01
Close Date: 2022-02-28
Grant: Open
The HDRUK/Turing Wellcome PhD Programme in Health Data Science
Open Date: 2020-07-01
Close Date: 2028-06-30
Articles (6)
Year:
2023
Objectives Successful delivery of digital health interventions is affected by multiple real-world factors. These factors may be identified in routinely collected, ecologically valid data from these interventions. We propose ideas for exploring these data, focusing on interventions targeting complex, comorbid conditions. Materials and Methods This study retrospectively explores pre-post data collected between 2016 and 2019 from users of digital cognitive behavioral therapy (CBT)—containing psychoeducation and practical exercises—for substance use disorder (SUD) at UK addiction services. To identify factors associated with heterogenous user responses to the technology, we employed multivariable and multivariate regressions and random forest models of user-reported questionnaire data. Results The dataset contained information from 14 078 individuals of which 12 529 reported complete data at baseline and 2925 did so again after engagement with the CBT. Ninety-three percent screened positive for dependence on 1 of 43 substances at baseline, and 73% screened positive for anxiety or depression. Despite pre-post improvements independent of user sociodemographics, women reported more frequent and persistent symptoms of SUD, anxiety, and depression. Retention—minimum 2 use events recorded—was associated more with deployment environment than user characteristics. Prediction accuracy of post-engagement outcomes was acceptable (Area Under Curve [AUC]: 0.74–0.79), depending non-trivially on user characteristics. Discussion Traditionally, performance of digital health interventions is determined in controlled trials. Our analysis showcases multivariate models with which real-world data from these interventions can be explored and sources of user heterogeneity in retention and symptom reduction uncovered. Conclusion Real-world data from digital health interventions contain information on natural user-technology interactions which could enrich results from controlled trials.
Year:
2023
Year:
2022
Year:
2021
Year:
2020
Year:
2020
Collaborators (7)
Rachel Plachcinski
City, University of London
Beck Taylor
University of Birmingham
Kelly-Ann Eastwood
Honorary lecturer
Queen's University Belfast
Amaya Azcoaga-Lorenzo
University of St. Andrews
Holly Hope
The University of Manchester
Tatjana Sauka-Spengler
Professor of Developmental Genomics and Gene Regulation
University of Oxford
Stephanie Jones
University of Oxford
Make your next move.
Prepare your application
Review drafts before you send them.